⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Pancreatic Cancer Early Detection Consortium

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Pancreatic Cancer Early Detection Consortium

Official Title: Pancreatic Cancer Early Detection Consortium

Study ID: NCT04970056

Interventions

Study Description

Brief Summary: The purpose of the Pancreatic Cancer Early Detection (PRECEDE) Consortium is to conduct research on multiple aspects of early detection and prevention of pancreatic ductal adenocarcinoma (PDAC) by establishing a multisite cohort of individuals with family history of PDAC and/or individuals carrying pathogenic/likely pathogenic germline variants (PGVs) in genes linked to PDAC risk for longitudinal follow up.

Detailed Description: The main objective of the PRECEDE Consortium is to build a shared resource to drive research in critical areas necessary for early detection and prevention of PDAC. The PRECEDE Consortium is an observational prospective cohort study, with single or serial biosample collection (every 6-12 months) in defined high-risk groups. A standardized procedure for collection and processing of human blood for the PRECEDE Consortium will be applied to all blood samples collected as part of the study. Barcoded samples will be stored at the clinical centers, using the specific labels for the PRECEDE study and corresponding data will be entered into the study database. Clinical data and outcomes will be obtained from institutional databases or clinical records to correlate patient information with laboratory results from biospecimens obtained for research. Patients will be followed by their attending physician and receive the standard follow-up care after the procedure in which biospecimen was obtained. It is the intent that biospecimens will be made available to all consortium investigators.

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: Yes

Locations

Mayo Clinic Arizona, Phoenix, Arizona, United States

Honor Health Research Institute, Scottsdale, Arizona, United States

Providence Health and Services, Burbank, California, United States

City of Hope, Duarte, California, United States

UC San Diego Moores Cancer Center, La Jolla, California, United States

Cedars-Sinai Medical Center, Los Angeles, California, United States

UCLA Health, Los Angeles, California, United States

UC Irvine Health, Orange, California, United States

UC Davis, Sacramento, California, United States

University of California, San Francisco (UCSF), San Francisco, California, United States

Yale University, New Haven, Connecticut, United States

Mayo Clinic Jacksonville, Jacksonville, Florida, United States

University of Miami, Miami, Florida, United States

Moffitt Cancer Center, Tampa, Florida, United States

Emory University Hospital, Atlanta, Georgia, United States

Illinois CancerCare, Bloomington, Illinois, United States

University of Chicago Medicine, Chicago, Illinois, United States

NorthShore University HealthSystem, Evanston, Illinois, United States

Kansas University Medical Center, Kansas City, Kansas, United States

Massachusetts General Hospital, Boston, Massachusetts, United States

Umass Memorial Medical Center, Worcester, Massachusetts, United States

University of Michigan, Ann Arbor, Michigan, United States

Beaumont/Corewell Health, Royal Oak, Michigan, United States

University of Nebraska Medical Center, Omaha, Nebraska, United States

Hackensack Meridian Health, Hackensack, New Jersey, United States

Icahn School of Medicine At Mount Sinai, New York, New York, United States

Columbia University Irving Medical Center, New York, New York, United States

University of Rochester Medical Center, Rochester, New York, United States

The Ohio State University, Columbus, Ohio, United States

Oregon Health & Science University, Portland, Oregon, United States

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

University of Pittsburgh Medical Center (Upmc), Pittsburgh, Pennsylvania, United States

University of Tennessee Graduate School of Medicine, Knoxville, Tennessee, United States

The University of Texas Southwestern Medical Center, Dallas, Texas, United States

MD Anderson Center, Houston, Texas, United States

Intermountain Health, Saint George, Utah, United States

Huntsman Cancer Institute, Salt Lake City, Utah, United States

Inova Schar Cancer Institute, Fairfax, Virginia, United States

VCU Massey Cancer Center, Richmond, Virginia, United States

University of Washington, Seattle, Washington, United States

British Columbia Cancer Agency, Vancouver, British Columbia, Canada

Uhn Mount Sinai Hospital, Toronto, Ontario, Canada

McGill University Health Centre, Montreal, Quebec, Canada

Semmelweis University Department of Pancreatic Disorders, Budapest, , Hungary

Landspitali University Hospital, Reykjavík, , Iceland

Sheba Medical Center, Ramat Gan, , Israel

Azienda Ospedaliera Universitaria Integrata Verona, Verona, , Italy

National Cancer Center of Singapore, Singapore, , Singapore

Ramón y Cajal University Hospital, Madrid, , Spain

National Cheng Kung University Hospital (NCKUH), Tainan, Taiwan T.o.c., Taiwan

University of Liverpool, Liverpool, , United Kingdom

Contact Details

Name: Diane Simeone, MD

Affiliation: UC San Diego Moores Cancer Center

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: